Cargando…

Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats

BACKGROUND: The deficiency in 1α, 25-dihydroxyvitamin D3 (VD3) seems to increase the risk for neurodegenerative pathologies, including Parkinson’s disease (PD). The majority of its actions are mediated by the transcription factor, VD3 receptor (VD3R). METHODS: The neuroprotective effects of VD3 were...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Ludmila A R, Lopes, Maria Janice P, Costa, Roberta O, Lima, Francisco Arnaldo V, Neves, Kelly Rose T, Calou, Iana B F, Andrade, Geanne M, Viana, Glauce S B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119240/
https://www.ncbi.nlm.nih.gov/pubmed/30170624
http://dx.doi.org/10.1186/s12974-018-1266-6
_version_ 1783352048528392192
author Lima, Ludmila A R
Lopes, Maria Janice P
Costa, Roberta O
Lima, Francisco Arnaldo V
Neves, Kelly Rose T
Calou, Iana B F
Andrade, Geanne M
Viana, Glauce S B
author_facet Lima, Ludmila A R
Lopes, Maria Janice P
Costa, Roberta O
Lima, Francisco Arnaldo V
Neves, Kelly Rose T
Calou, Iana B F
Andrade, Geanne M
Viana, Glauce S B
author_sort Lima, Ludmila A R
collection PubMed
description BACKGROUND: The deficiency in 1α, 25-dihydroxyvitamin D3 (VD3) seems to increase the risk for neurodegenerative pathologies, including Parkinson’s disease (PD). The majority of its actions are mediated by the transcription factor, VD3 receptor (VD3R). METHODS: The neuroprotective effects of VD3 were investigated on a PD model. Male Wistar rats were divided into the following groups: sham-operated (SO), 6-OHDA-lesioned (non-treated), and 6-OHDA-lesioned and treated with VD3 (7 days before the lesion, pre-treatment or for 14 days after the 6-OHDA striatal lesion, post-treatment). Afterwards, the animals were subjected to behavioral tests and euthanized for striatal neurochemical and immunohistochemical assays. The data were analyzed by ANOVA and the Tukey test and considered significant for p < 0.05. RESULTS: We showed that pre- or post-treatments with VD3 reversed behavioral changes and improved the decreased DA contents of the 6-OHDA group. In addition, VD3 reduced the oxidative stress, increased (TH and DAT), and reduced (TNF-alpha) immunostainings in the lesioned striata. While significant decreases in VD3R immunoreactivity were observed after the 6-OHDA lesion, these changes were blocked after VD3 pre- or post-treatments. We showed that VD3 offers neuroprotection, decreasing behavioral changes, DA depletion, and oxidative stress. In addition, it reverses partially or completely TH, DAT, TNF-alpha, and VD3R decreases of immunoreactivities in the non-treated 6-OHDA group. CONCLUSIONS: Taken together, VD3 effects could result from its anti-inflammatory and antioxidant actions and from its actions on VD3R. These findings should stimulate translational research towards the VD3 potential for prevention or treatment of neurodegenerative diseases, as PD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-018-1266-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6119240
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61192402018-09-05 Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats Lima, Ludmila A R Lopes, Maria Janice P Costa, Roberta O Lima, Francisco Arnaldo V Neves, Kelly Rose T Calou, Iana B F Andrade, Geanne M Viana, Glauce S B J Neuroinflammation Research BACKGROUND: The deficiency in 1α, 25-dihydroxyvitamin D3 (VD3) seems to increase the risk for neurodegenerative pathologies, including Parkinson’s disease (PD). The majority of its actions are mediated by the transcription factor, VD3 receptor (VD3R). METHODS: The neuroprotective effects of VD3 were investigated on a PD model. Male Wistar rats were divided into the following groups: sham-operated (SO), 6-OHDA-lesioned (non-treated), and 6-OHDA-lesioned and treated with VD3 (7 days before the lesion, pre-treatment or for 14 days after the 6-OHDA striatal lesion, post-treatment). Afterwards, the animals were subjected to behavioral tests and euthanized for striatal neurochemical and immunohistochemical assays. The data were analyzed by ANOVA and the Tukey test and considered significant for p < 0.05. RESULTS: We showed that pre- or post-treatments with VD3 reversed behavioral changes and improved the decreased DA contents of the 6-OHDA group. In addition, VD3 reduced the oxidative stress, increased (TH and DAT), and reduced (TNF-alpha) immunostainings in the lesioned striata. While significant decreases in VD3R immunoreactivity were observed after the 6-OHDA lesion, these changes were blocked after VD3 pre- or post-treatments. We showed that VD3 offers neuroprotection, decreasing behavioral changes, DA depletion, and oxidative stress. In addition, it reverses partially or completely TH, DAT, TNF-alpha, and VD3R decreases of immunoreactivities in the non-treated 6-OHDA group. CONCLUSIONS: Taken together, VD3 effects could result from its anti-inflammatory and antioxidant actions and from its actions on VD3R. These findings should stimulate translational research towards the VD3 potential for prevention or treatment of neurodegenerative diseases, as PD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-018-1266-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-31 /pmc/articles/PMC6119240/ /pubmed/30170624 http://dx.doi.org/10.1186/s12974-018-1266-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lima, Ludmila A R
Lopes, Maria Janice P
Costa, Roberta O
Lima, Francisco Arnaldo V
Neves, Kelly Rose T
Calou, Iana B F
Andrade, Geanne M
Viana, Glauce S B
Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats
title Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats
title_full Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats
title_fullStr Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats
title_full_unstemmed Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats
title_short Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats
title_sort vitamin d protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119240/
https://www.ncbi.nlm.nih.gov/pubmed/30170624
http://dx.doi.org/10.1186/s12974-018-1266-6
work_keys_str_mv AT limaludmilaar vitamindprotectsdopaminergicneuronsagainstneuroinflammationandoxidativestressinhemiparkinsonianrats
AT lopesmariajanicep vitamindprotectsdopaminergicneuronsagainstneuroinflammationandoxidativestressinhemiparkinsonianrats
AT costarobertao vitamindprotectsdopaminergicneuronsagainstneuroinflammationandoxidativestressinhemiparkinsonianrats
AT limafranciscoarnaldov vitamindprotectsdopaminergicneuronsagainstneuroinflammationandoxidativestressinhemiparkinsonianrats
AT neveskellyroset vitamindprotectsdopaminergicneuronsagainstneuroinflammationandoxidativestressinhemiparkinsonianrats
AT calouianabf vitamindprotectsdopaminergicneuronsagainstneuroinflammationandoxidativestressinhemiparkinsonianrats
AT andradegeannem vitamindprotectsdopaminergicneuronsagainstneuroinflammationandoxidativestressinhemiparkinsonianrats
AT vianaglaucesb vitamindprotectsdopaminergicneuronsagainstneuroinflammationandoxidativestressinhemiparkinsonianrats